Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 37.20%145.4M | 258.18%196.38M | 269.80%203.8M | 151.85%179.96M | -43.08%105.98M | -82.33%54.83M | -28.38%55.11M | 76.85%71.46M | 232.54%186.2M | 97.68%310.28M |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | 0.00%709K | 0.00%709K | 0.00%709K | 0.00%709K | -8.32%709K |
| Notes receivable and accounts receivable | 17.58%38.38M | 21.96%39.44M | 3.56%32.46M | -14.78%29.33M | 15.43%32.64M | 33.49%32.34M | 55.39%31.34M | 70.33%34.41M | 38.84%28.28M | 38.22%24.23M |
| -Accounts receivable | 17.58%38.38M | 21.96%39.44M | 3.56%32.46M | -14.78%29.33M | 15.43%32.64M | 33.49%32.34M | 55.39%31.34M | 70.33%34.41M | 38.84%28.28M | 38.22%24.23M |
| Other receivables (including interest and dividends) | 56.33%2.8M | 51.32%2.48M | 23.33%2.1M | 10.76%1.69M | -43.01%1.79M | -30.43%1.64M | -25.60%1.7M | -26.71%1.52M | 5.11%3.15M | -13.22%2.35M |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --345K |
| -Other receivable | ---- | 51.32%2.48M | ---- | ---- | ---- | -18.49%1.64M | ---- | -26.71%1.52M | ---- | -25.93%2.01M |
| Advance payment | 96.51%21.82M | 14.70%24.06M | 169.03%17.54M | 107.55%15.17M | 53.56%11.1M | 235.49%20.98M | -3.67%6.52M | 82.69%7.31M | 177.22%7.23M | -6.75%6.25M |
| Inventories | 18.11%107.03M | 31.70%99.62M | 21.88%105.6M | 45.64%105.18M | 0.57%90.62M | 8.13%75.64M | -20.87%86.64M | -35.50%72.22M | -11.91%90.11M | -28.50%69.95M |
| Other current assets | --20.34K | --14.9K | --0 | --7.32K | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current assets | 30.28%315.45M | 94.48%362M | 98.60%361.5M | 76.59%331.34M | -23.29%242.13M | -55.02%186.13M | -15.88%182.03M | 4.61%187.63M | 70.67%315.67M | 46.46%413.77M |
| Non Current assets | ||||||||||
| Other debt investment | --0 | ---- | 3.22%32.7M | -22.35%32.45M | --32.2M | --31.94M | --31.68M | --41.8M | ---- | ---- |
| Fixed assets | ---- | -6.69%1.07B | ---- | ---- | ---- | 10.96%1.15B | ---- | 28.14%1.14B | ---- | 58.42%1.03B |
| Fixed assets liquidation | ---- | --0 | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 |
| Constru in process | ---- | 1.94%3.32M | ---- | ---- | ---- | -94.32%3.26M | ---- | -79.92%34.03M | ---- | -69.73%57.43M |
| Construction materials | ---- | 389.26%505.98K | ---- | ---- | ---- | -97.75%103.42K | ---- | -90.80%110.28K | ---- | --4.61M |
| Productive biological assets | 1.10%141.76M | 7.09%144.82M | 0.60%134.89M | 6.20%127.3M | 21.50%140.22M | 27.63%135.23M | 18.36%134.09M | -2.59%119.86M | 4.75%115.41M | 6.25%105.96M |
| Intangible assets | -1.72%50.48M | -1.80%50.88M | -3.50%50.44M | -3.47%50.9M | -3.44%51.36M | -3.37%51.82M | 1.90%52.27M | 8.84%52.73M | 12.59%53.19M | 15.61%53.62M |
| Long deferred expense | 2.61%10.55M | 4.50%11.4M | 10.56%12.29M | 15.82%13.16M | -10.87%10.28M | -7.41%10.91M | 23.94%11.11M | 23.40%11.36M | 5.93%11.54M | 12.37%11.78M |
| Usufruct assets | -11.86%15.95M | -11.52%16.48M | -7.72%17.07M | -7.49%17.56M | -12.02%18.09M | -11.69%18.63M | -14.47%18.5M | -14.34%18.98M | -11.18%20.57M | -11.36%21.1M |
| Other non current assets | 78.73%10.35M | -69.11%1.93M | -57.11%1.69M | -85.06%1.69M | -82.55%5.79M | -43.66%6.23M | -80.61%3.93M | -2.35%11.3M | -38.20%33.18M | -82.99%11.06M |
| Total non current assets | -6.85%1.29B | -7.51%1.3B | -5.51%1.34B | -5.17%1.36B | 2.93%1.39B | 8.15%1.4B | 11.93%1.42B | 12.18%1.43B | 12.75%1.35B | 19.45%1.3B |
| Total assets | -1.34%1.61B | 4.42%1.66B | 6.32%1.7B | 4.32%1.69B | -2.04%1.63B | -7.11%1.59B | 7.88%1.6B | 11.25%1.62B | 20.50%1.67B | 25.02%1.71B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | --0 | ---- | --0 | --10.4M | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | -36.22%45.42M | -4.42%60.05M | -6.02%58.96M | -31.38%57.02M | -5.19%71.22M | -29.37%62.83M | -34.45%62.73M | -29.35%83.1M | -27.57%75.12M | -5.91%88.95M |
| -Accounts payable | -36.22%45.42M | -4.42%60.05M | -6.02%58.96M | -31.38%57.02M | -5.19%71.22M | -29.37%62.83M | -34.45%62.73M | -29.35%83.1M | -27.57%75.12M | -5.91%88.95M |
| Contract liabilities | -5.29%39.41M | 127.78%49.09M | 263.96%65.4M | 421.15%77.71M | 156.43%41.61M | 84.50%21.55M | -38.56%17.97M | -16.77%14.91M | -19.89%16.23M | -15.59%11.68M |
| Salaries payable | 57.10%23.23M | 74.58%22.39M | 102.27%25.13M | 29.54%26.89M | 11.53%14.78M | -9.70%12.83M | -4.34%12.42M | 44.99%20.76M | 0.14%13.26M | 5.82%14.2M |
| Taxs payable | -23.25%795.96K | -12.51%651.62K | 45.42%813.45K | 4.05%780.34K | 51.12%1.04M | 3.02%744.79K | -24.70%559.39K | 15.39%749.96K | 8.23%686.28K | 30.94%722.94K |
| Other payable (including interest and dividends) | -80.61%7.2M | -82.15%6.9M | -74.03%10.63M | -67.76%13.85M | -11.31%37.15M | -4.72%38.63M | -23.36%40.95M | -17.64%42.95M | -6.46%41.89M | -49.64%40.55M |
| -Other payable | ---- | -82.15%6.9M | ---- | ---- | ---- | -4.72%38.63M | ---- | -17.64%42.95M | ---- | -4.55%40.55M |
| Non current liabilities due within one year | -51.93%78.73M | -37.36%75.06M | 93.85%143.86M | 89.74%171.7M | 94.34%163.77M | 41.65%119.83M | -13.02%74.21M | 1.69%90.49M | -0.35%84.27M | 21.72%84.6M |
| Total current liabilities | -40.90%194.78M | -16.49%214.13M | 45.94%304.79M | 41.66%358.36M | 42.40%329.57M | 6.53%256.42M | -24.72%208.85M | -13.26%252.96M | -13.38%231.44M | -11.63%240.71M |
| Current liabilities | ||||||||||
| Long term loan | -28.61%200.04M | -30.97%234.54M | -37.87%239.24M | -28.95%248.86M | -21.00%280.2M | -4.09%339.75M | -2.63%385.05M | 3.82%350.25M | 24.78%354.7M | 34.56%354.24M |
| Bonds payable | 7.36%286.4M | 7.73%282.09M | 8.09%277.76M | 8.29%273.03M | 8.27%266.76M | 8.44%261.84M | --256.98M | --252.12M | --246.38M | --241.46M |
| Estimate liabilities | -21.12%2.21M | -3.20%2.56M | -17.35%2.23M | -5.89%2.08M | 13.99%2.8M | -0.41%2.64M | 38.32%2.7M | 37.40%2.21M | 757.63%2.46M | 754.94%2.65M |
| Long term deferred income | 28.25%7.66M | 28.26%7.99M | 27.60%8.31M | 27.00%8.63M | -15.67%5.97M | -15.23%6.23M | -11.05%6.51M | -10.51%6.8M | 45.79%7.08M | 102.14%7.35M |
| Lease liabilities | -12.36%12.28M | -11.88%12.21M | -12.29%12.08M | -11.00%13.55M | -9.84%14.01M | -10.26%13.85M | -9.82%13.77M | -9.55%15.22M | -10.25%15.54M | -10.23%15.44M |
| Total non current liabilities | -10.73%508.59M | -13.60%539.39M | -18.86%539.62M | -12.84%546.16M | -9.01%569.74M | 0.51%624.32M | 58.34%665.01M | 72.43%626.6M | 104.15%626.15M | 118.40%621.15M |
| Total liabilities | -21.79%703.37M | -14.44%753.52M | -3.37%844.42M | 2.84%904.51M | 4.86%899.31M | 2.19%880.74M | 25.30%873.86M | 34.28%879.57M | 49.43%857.59M | 54.79%861.86M |
| Shareholders equity | ||||||||||
| Paid-in capital | -1.02%187.57M | -1.02%187.57M | -1.02%187.56M | -1.02%187.56M | 0.00%189.5M | 0.00%189.5M | -0.37%189.5M | -0.37%189.5M | -0.37%189.5M | -0.37%189.5M |
| Other equity instruments | -0.09%86.64M | -0.08%86.65M | -0.03%86.69M | -0.03%86.69M | -0.00%86.72M | -0.00%86.72M | --86.72M | --86.72M | --86.72M | --86.72M |
| Capital reserve funds | -7.60%285.51M | -7.27%285.48M | -6.98%285.31M | -6.64%285.31M | 2.60%309.01M | 2.44%307.86M | -0.20%306.72M | -0.36%305.59M | -1.56%301.18M | -2.35%300.52M |
| Surplus reserve funds | 9.97%47.29M | 9.97%47.29M | 10.15%47.37M | 9.97%47.29M | 0.00%43M | 0.00%43M | 0.00%43M | 0.00%43M | 2.06%43M | 2.06%43M |
| Retained profit | 154.45%321.24M | 205.71%322.9M | 119.58%274.26M | 30.07%175.31M | -39.82%126.25M | -58.36%105.62M | -55.14%124.91M | -53.45%134.79M | -30.30%209.79M | -16.66%253.64M |
| Less:Treasury stock | -1.58%21.97M | -1.58%21.97M | -1.60%21.97M | --0 | 0.00%22.32M | 0.00%22.32M | -28.19%22.32M | -28.19%22.32M | -28.19%22.32M | -28.19%22.32M |
| Shareholders equity without minority interests | 23.78%906.29M | 27.81%907.92M | 17.94%859.23M | 6.09%782.16M | -9.37%732.16M | -16.53%710.38M | -7.54%728.53M | -7.65%737.28M | -0.04%807.87M | 4.64%851.06M |
| Total shareholder equity | 23.78%906.29M | 27.81%907.92M | 17.94%859.23M | 6.09%782.16M | -9.37%732.16M | -16.53%710.38M | -7.54%728.53M | -7.65%737.28M | -0.04%807.87M | 4.64%851.06M |
| Total liabilityies and equity | -1.34%1.61B | 4.42%1.66B | 6.32%1.7B | 4.32%1.69B | -2.04%1.63B | -7.11%1.59B | 7.88%1.6B | 11.25%1.62B | 20.50%1.67B | 25.02%1.71B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.